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Abstract
Background: The aim of the present work was to characterize the electrophysiological effects of the non-steroidal anti-
inflammatory drug diclofenac and to study the possible proarrhythmic potency of the drug in ventricular muscle.
Methods: Ion currents were recorded using voltage clamp technique in canine single ventricular cells and action potentials
were obtained from canine ventricular preparations using microelectrodes. The proarrhythmic potency of the drug was
investigated in an anaesthetized rabbit proarrhythmia model.
Results: Action potentials were slightly lengthened in ventricular muscle but were shortened in Purkinje fibers by diclofenac
(20 mM). The maximum upstroke velocity was decreased in both preparations. Larger repolarization prolongation was
observed when repolarization reserve was impaired by previous BaCl2 application. Diclofenac (3 mg/kg) did not prolong
while dofetilide (25 mg/kg) significantly lengthened the QTc interval in anaesthetized rabbits. The addition of diclofenac
following reduction of repolarization reserve by dofetilide further prolonged QTc. Diclofenac alone did not induce Torsades
de Pointes ventricular tachycardia (TdP) while TdP incidence following dofetilide was 20%. However, the combination of
diclofenac and dofetilide significantly increased TdP incidence (62%). In single ventricular cells diclofenac (30 mM) decreased
the amplitude of rapid (IKr) and slow (IKs) delayed rectifier currents thereby attenuating repolarization reserve. L-type calcium
current (ICa) was slightly diminished, but the transient outward (Ito) and inward rectifier (IK1) potassium currents were not
influenced.
Conclusions: Diclofenac at therapeutic concentrations and even at high dose does not prolong repolarization markedly and
does not increase the risk of arrhythmia in normal heart. However, high dose diclofenac treatment may lengthen
repolarization and enhance proarrhythmic risk in hearts with reduced repolarization reserve.
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Introduction
Drug induced prolongation of cardiac repolarization that
manifests on the surface ECG as QT interval lengthening is
considered to represent enhanced risk for proarrhythmia and
sudden cardiac death. Recently, several non-cardiac drugs were
withdrawn from the market and the development of numerous
compounds were halted at the preclinical stage due to their
proarrhythmic effects, indicating that safety pharmacological
concerns and monitoring in this respect are now more vigorous
than they were in the past. Therefore, it can be speculated that
several drugs approved earlier and used widely today would not
reach clinical phase of development due to failing at current, more
rigorous safety pharmacology tests. However, the vast majority of
drugs developed earlier and successfully applied today do not
enhance proarrhythmic risk in the normal heart. On the other
hand, there are certain situations when cardiac repolarization
reserve [1–3] is attenuated due to ion channel protein encoding
gene mutations, diseases or even lifestyle when otherwise minor
subthreshold drug effects on cardiac repolarization may enhance
repolarization instability with subsequently elevated proarrhyth-
mic risk.
As a possible example for such situations, a number of sudden
deaths of young athletes were reported in the past several years.
The majority of these events were sudden cardiac deaths (SCD)
attributed to ventricular fibrillation. Fortunately, the incidence of
SCD of young athletes is quite low (around 1–2:100 000),
however, it is still 2–4 times more frequent than in the age-
matched population not participating in competitive sport [4].
There are a number of factors that can play a significant role in the
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development of SCD in young athletes [5]. Cardiac hypertrophy is
considered as one of the most important risk factors that has been
associated with a characteristic electrical remodeling [6] that
involves the downregulation of cardiac potassium channels,
including IKs, a repolarizing current that has a uniquely important
role in cardiac ventricular repolarization reserve [7,8]. Further
important factors that influence arrhythmia disposition include
various other cardiovascular diseases, hypokalemia, doping and
seemingly harmless medications.
These medications may include non-steroid anti-inflammatory
(NSAID) drugs often taken by athletes to alleviate pain related to
sports injuries. Diclofenac is such a drug that is widely used for this
purpose. Diclofenac intake has been associated with sudden death
in four professional soccer players in a television show, however,
scientifically this claim was not very well documented [9]. In this
report, the pathologist Jørgen Lange Thomsen attributed these
fatalities to coronary constriction as a possible consequence of
cyclooxygenase enzyme (COX) inhibition [9]. However, one can
speculate that different mechanisms may also be involved in-
cluding direct cardiac electrophysiological effects on potassium
channels with consequent changes in ventricular repolarization.
Diclofenac is a nonselective NSAID drug, which blocks COX-1
and COX-2 enzymes and is widely used as an anti-inflammatory
and analgesic drug. There is growing concern regarding increased
cardiovascular risks of NSAIDs application [10–12], however, very
little is known about the cardiac electrophysiological effect of these
drugs. Therefore, detailed characterization of the possible effects
of diclofenac, one of the most frequently applied NSAIDs, on
ventricular repolarization and transmembrane ionic currents and
further consideration of the possible proarrhythmic potency of the
drug seems reasonable since it can not be ruled out that its possible
proarrhythmic potency might contribute to the higher incidence of
SCD in young athletes. Such studies are justified by the fact that
diclofenac is very often used in large doses for the treatment of
sports injuries [13].
In the present study, the cellular electrophysiological effects of
diclofenac were characterized including its effects on the main
transmembrane ionic currents in single ventricular myocytes as
well as on the action potential characteristics in canine isolated
ventricular muscle and Purkinje fibers. The possible proarrhyth-
mic potency of the drug was also investigated in an anaesthetized
rabbit proarrhythmia model.
Methods
Ethics Statement
All experiments were carried out in compliance with the Guide
for the Care and Use of Laboratory Animals (USA NIH publication NO
85–23, revised 1996) and conformed to the Directive 2010/63/
EU of the European Parliament. The protocols have been
approved by the Ethical Committee for the Protection of Animals
in Research of the University of Szeged, Szeged, Hungary
(approval number: I-74-5-2012) and by the Department of Animal
Health and Food Control of the Ministry of Agriculture and Rural
Development (authority approval number XIII/1211/2012).
Conventional Microelectrode Technique
Adult mongrel dogs (8–14 kg) of either sex were used. Following
sedation (xylazine, 1 mg/kg, i.v.) and anaesthesia (thiopental,
30 mg/kg i.v.), the heart was rapidly removed through right lateral
thoracotomy. The hearts were immediately rinsed in oxygenated
modified Locke’s solution containing (in mM): NaCl 120, KCl 4,
CaCl2 1.0, MgCl2 1, NaHCO3 22, and glucose 11. The pH of this
solution was set between 7.35 and 7.4 when saturated with the
mixture of 95% O2 and 5% CO2 at 37uC. Isolated muscle
preparations obtained from the right ventricle and Purkinje fibers
were individually mounted in a tissue chamber with a volume of
50 ml. These preparations were stimulated through a pair of
platinum electrodes in contact with the preparation using
rectangular current pulses of 2 ms duration. These stimuli were
delivered at a constant cycle length of 1 s (500 ms for Purkinje
fibers) for at least 60 min allowing the preparation to equilibrate
before the measurements were initiated. Transmembrane poten-
tials were recorded using conventional glass microelectrodes, filled
with 3 M KCl and having tip resistances of 5–20 MV, connected
to the input of a high impedance electrometer (Experimetria, type
309, Budapest, Hungary) which was coupled to a dual beam
oscilloscope. The maximum diastolic potential, action potential
amplitude, maximum upstroke velocity (Vmax) and action potential
duration measured at 50% and 90% of repolarization (APD50 and
APD90, respectively) were off-line determined using a home-made
software running on an IBM compatible computer equipped with
an ADA 3300 analogue-to-digital data acquisition board (Real
Time Devices Inc., State Collage, PA, USA) having a maximum
sampling frequency of 40 KHz. The following types of stimulation
were applied in the course of the experiments: stimulation with
a constant cycle length of 1000 ms (ventricular muscles);
stimulation with a constant cycle length of 500 ms (Purkinje
fibres); stimulation with different constant cycle lengths ranging
from 300 to 5000 ms (or to 2000 ms in the case of Purkinje fibers
to prevent spontaneous diastolic depolarization at cycle lengths
longer than 2000 ms). Attempts were made to maintain the same
impalement throughout each experiment. In case an impalement
became dislodged, adjustment was attempted, and if the action
potential characteristics of the re-established impalement deviated
by less than 5% from the previous measurement, the experiment
continued.
Whole Cell Patch-clamp
Ventricular myocytes were enzymatically dissociated from dog
hearts using the segment perfusion technique as described earlier
in detail [7]. One drop of cell suspension was placed in
a transparent recording chamber mounted on the stage of an
inverted microscope. The myocytes were allowed to settle and
adhere to the bottom for at least 5 minutes before superfusion was
initiated. Only rod shaped cells with clear cross-striations were
used. Cells were superfused with HEPES-buffered Tyrode solution
containing (in mM): NaCl 144, NaH2PO4 0.4, KCl 4.0, CaCl2 1.8,
MgSO4 0.53, glucose 5.5, and HEPES 5.0. The pH was set to 7.4
and the temperature to 37oC.
Patch-clamp micropipettes were fabricated from borosilicate
glass capillaries (Harvard Apparatus Ltd, Edenbridge, Kent, UK)
using a micropipette puller (Flaming/Brown, type P-97, Sutter Co,
Novato, CA, USA). These electrodes had resistances between 1.5
and 2.5 MV when filled with pipette solution containing (in mM):
K-aspartate 100, KCl 40, ATP 5, MgCl2 5, EGTA 4, CaCl2 1.5
and HEPES 10. The pH of this solution was adjusted to 7.2 by
KOH. When measuring potassium currents, 1 mM nisoldipine
(gift from Bayer AG, Leverkusen, Germany) was added to the
external solution to eliminate L-type Ca2+ current (ICa). The slow
component of the delayed rectifier potassium current (IKs) was
inhibited by using the selective IKs blocker HMR 1556 (0.5 mM).
In some experiments, the rapid component of the delayed rectifier
potassium current (IKr) was blocked by 0.1 mM dofetilide. The L-
type calcium current was recorded in HEPES buffered Tyrode’s
solution containing 3 mM 4-aminopyridine in order to block the
transient outward potassium current (Ito) and a special K
+ free
pipette solution was used (composition in mM: CsOH 100, CsCl
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20, TEACl 20, MgATP 5, HEPES 10, EGTA 4, CaCl2 1.5, GTP
0.1, the pH was adjusted to 7.2 with aspartic acid). Membrane
currents were recorded with Axopatch 200B patch-clamp
amplifiers (Molecular Devices Inc., Sunnyvale, CA, USA) using
the whole-cell configuration of the patch-clamp technique. After
establishing a high resistance (1–10 GV) seal by gentle suction, the
cell membrane beneath the tip of the electrode was disrupted by
suction or application of short electrical pulses. The series
resistance typically ranged from 4 to 8 MV before compensation
(50%–80%). Experiments were discarded, when the series re-
sistance was high or substantially increased during the measure-
ment. Membrane currents were digitized after low-pass filtering at
1 kHz using analog-to-digital converters (Digidata 1322A and
1440A, Molecular Devices Inc., Sunnyvale, CA, USA) under
software control (pClamp 8 and 10, Molecular Devices Inc.,
Sunnyvale, CA, USA). The same software was used for off-line
analysis.
ECG Measurements in Anaesthetized Rabbits
Male New Zealand white rabbits (2–3 kg) were used for the
experiments. The animals were anaesthetized with thiopental
(50 mg/kg, i.v.) given into the marginal vein of the right ear. A
plastic catheter filled with isotonic saline containing 500 IU/mL
heparin was inserted into the left carotid artery for the
measurement of arterial blood pressure. The right jugular vein
was cannulated for i.v. drug administration. The animals were
allowed to stabilize for 20 min before baseline measurements were
taken.
The blood pressure and the electrocardiogram (limb leads I, II
and III) were continuously recorded (at 2 kHz), digitized and
stored on a computer for off-line analysis using National
Instruments data acquisition hardware (National Instruments,
Austin, TX, USA) and SPEL Advanced Haemosys software (v3.2,
Experimetria Ltd., Budapest, Hungary). The RR and QT
intervals were measured as the average of 10 beats. During the
measurement of the QT interval in anaesthetized rabbits, the
guidelines described by Farkas et al. [14] were followed. The
frequency corrected QT interval (QTc) was calculated by
a formula specifically worked out for anaesthetized rabbits by
Batey and Coker [15] for more accurate monitoring of heart rate
dependent changes in the QT interval, as follows: QTc=QT –
(0.704 * (RR-250)).
All intravenous infusions were administered using a program-
mable infusion pump (Terufusion TE-3, Terumo Europe, Leuven,
Belgium). The first group of rabbits received 3 mg/kg diclofenac
(Sigma-Aldrich, Hungary) in a 10 min infusion in a volume of
Figure 1. Effect of diclofenac on action potentials in canine right ventricular muscle preparations and in Purkinje fibers.
Representative superimposed records (top) demonstrating the effect of 20 mM diclofenac on action potential configuration at 1 s stimulation cycle
length (A, right ventricular muscle; B, Purkinje fiber). Cycle length dependent changes in action potential duration (APD90) measured under control
conditions and in the presence of 20 mM diclofenac (bottom) in canine right ventricular muscle preparations (A) and in Purkinje fibers (B). Data are
expressed as mean 6 SEM, n = number of measurements/number of animals.
doi:10.1371/journal.pone.0053255.g001
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2 ml/kg followed by 25 mg/kg dofetilide (Gedeon Richter Ltd.,
Budapest, Hungary) with 15 min equilibrium between infusions.
The second group was administered the same dose of compounds
in the reverse order.
Statistics
The incidence of TdP was compared using the x2–test, with
Yates’ correction. All other data are expressed as arithmetic mean
6 S.E.M. values. Statistical differences were evaluated with one-
way analysis of variance (ANOVA). Differences were considered
significant when p,0.05.
Results
Effects of Diclofenac on Action Potential
The effects of diclofenac on action potential configuration were
studied in canine right ventricular muscle preparations and
Purkinje fibers. The result obtained is shown in Figure 1A top
panel. Small, but statistically significant action potential lengthen-
ing was induced by diclofenac (20 mM) at a basic stimulation
frequency of 1 Hz in right ventricular muscle preparations (APD90
from 222.364.1 ms to 232.263.4 ms; APD50 from 185.365.7 ms
to 198.364.1 ms; n= 13/13 animals, p,0.05). The maximum
upstroke velocity was also decreased by the drug (control:
168.8615.7 V/s, 20 mM diclofenac: 136.6613.2 V/s, n= 13/13
animals, p,0.05) at cycle length of 1000 ms. To study the rate-
dependent effect of the drug on APD90, the preparations were
stimulated at cycle lengths ranging from 300 to 5000 ms. Under
these circumstances diclofenac produced a slight rate-independent
APD prolongation (Figure 1A bottom panel). In canine Purkinje
fibers, however, the drug significantly shortened the action
potential duration (APD90 from 248.1610.9 ms to
230.869.7 ms; APD50 from 177.8612.8 ms to 152.0612.5 ms;
n = 6 preparations/6 animals, p,0.05) and decreased Vmax (from
673.968.5 V/s, to 562.4627.0 V/s, n = 6 preparations/6 ani-
mals, p,0.05) at basic cycle length of 500 ms indicating a sodium
channel blocking property of the drug [16]. The shortening of
APD90 was rate-independent (Figure 1B).
The influence of diclofenac on action potential repolarization in
preparations with impaired repolarization reserve was also in-
vestigated. Repolarization reserve was greatly attenuated by the
application of 30 mM BaCl2, which partially blocks the inward
rectifier potassium current (IK1) in dog right ventricle [17]. BaCl2
lengthened APD in a reverse frequency dependent manner
(Figure 2). In the presence of BaCl2, 20 mM diclofenac was added
to these preparations. The drug induced a marked further
lengthening relative to the APD90 values measured after the
administration of BaCl2 (APD90: diclofenac: 309.8615.2 ms vs.
BaCl2: 283.5615.3 ms; APD50: 241.0610.3 ms vs.
225.2612.6 ms; n= 11 preparations/9 animals, p,0.05, at cycle
length of 1000 ms), i.e. APD lengthening effect of diclofenac was
significantly augmented in preparations where the ‘‘repolarization
reserve’’ was attenuated by previous application of BaCl2
(Figure 2). Under these circumstances the drug produced reverse
rate-dependent APD prolongation (Figure 2B).
Rationale for the Use of Anaesthetized Rabbit
Proarrhythmia Model
Since the introduction of the Carlsson’s rabbit proarrhythmia
model [18], the anaesthetized rabbit has been extensively used in
different in vivo proarrhythmia studies for the assessement of
arrhythmia risk associated with a compound of interest (for
a comprehensive review see [19]). Therefore, two sets of
experiments were also carried out in anaesthetized rabbits
investigating the effects of diclofenac alone and in combination
with the IKr blocker dofetilide (impairing repolarization reserve) on
cardiac repolarization and the development of Torsades de Pointes
ventricular tachycardia (TdP).
Figure 2. Effect of diclofenac on action potential repolarization in canine right ventricular preparations with impaired
repolarization reserve. (A) Representative superimposed action potentials recorded from canine right ventricular muscle preparation at cycle
length of 1 s. In these experiments 30 mM BaCl2 was applied to attenuate the repolarization reserve prior to 20 mM diclofenac superfusion. (B) Cycle
length dependent changes in APD90 measured under the specified experimental conditions in canine right ventricular muscle preparation. Data are
expressed as mean 6 SEM, n = number of measurements/number of animals.
doi:10.1371/journal.pone.0053255.g002
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Effect of Diclofenac, Dofetilide and their Combinations
on QTc, RR Intervals and Incidence of TdP in
Anaesthetized Rabbits
The QT and RR intervals were not different in baseline
conditions between the two groups of anaesthetized rabbits, and
were 147.664.95 vs. 144.967.18 ms and 242.864.28 vs.
229.466.02 ms, n= 15 and 13 animals, respectively, all p.0.05.
Diclofenac (3 mg/kg) did not increase the RR interval either when
given first (230.266.98 vs. 229.466.02 ms in control, p.0.05) or
when it was administered following dofetilide infusion
(252.167.73 ms vs 250.465.97 ms, p.0.05). Dofetilide, on the
other hand, increased the RR interval both when given first
(250.465.97 ms vs. 242.864.28 ms, p,0.05) and when it was
administered following diclofenac infusion (240.368.21 ms vs.
230.266.98 ms, p,0.01). As shown on Figure 3A, diclofenac
(3 mg/kg) did not change the QTc interval, while as expected,
dofetilide (25 mg/kg) significantly lengthened QTc in anaesthe-
tized rabbits. The combination of diclofenac and dofetilide
significantly prolonged QTc, irrespective of the order of admin-
istration (Fig. 3A). Figure 3B and C illustrate the incidence of
Torsades de Pointes arrhythmias in anaesthetized rabbits following
the administration of diclofenac, dofetilide and their combination.
Importantly, diclofenac alone did not induce TdP in any of the 13
animals examined, while TdP incidence following dofetilide was
20%, which corresponds well with our previous observations in
this model [20]. However, the animals were not devoid of
arrhythmias after diclofenac administration: 8 out of 13 exhibited
frequent ventricular extra beats, and 7 out of 13 developed
bigeminy. On the other hand, the combination of diclofenac and
dofetilide led to a significant increase in the incidence of TdP and
the increase was highest (62%) when diclofenac was administered
first, indicating that further potassium channel inhibition following
prior impairment of repolarization reserve can lead to increased
frequency of serious arrhythmia development (Fig. 3B).
Effects of Diclofenac on Transmembrane Ionic Currents
The effects of the drug on the 4-aminopyridine sensitive Ito, as
well as on IK1, IKr, IKs and ICa were investigated in canine
ventricular myocytes. As shown in Figure 4A and 4B, diclofenac
(even at 50 mM concentration) did not influence Ito or IK1
currents. Ito current was activated by 300 ms long depolarizing
voltage pulses from the holding potential of 290 mV to test
potentials ranging from 220 to +60 mV with a pulse frequency of
0.33 Hz. The amplitude of Ito was measured as the difference
between the peak and the sustained current at the end of the
voltage pulse. IK1 current was measured as the steady-state current
level at the end of the 300 ms long voltage pulse in the voltage
range of 2100 to 0 mV with a pulse frequency of 0.33 Hz. The
holding potential was 290 mV.
IKr and IKs were measured using 1000 ms (IKr) or 5000 ms-long
(IKs) test pulses between 230 mV and +50 mV (IKr) or 220 to
+50 mV (IKs). The holding potential was 280 mV and during IKr
measurements 500 ms long prepulse to 240 mV was applied in
order to ensure the baseline region. The pulse frequency was
0.05 Hz (IKr) or 0.1 Hz (IKs). The decaying tail current at
240 mV after the test pulse was assessed as IKr or IKs. The
amplitudes of the IKr and IKs tail currents were determined as the
difference between the peak tail current and the steady-state
current level at 240 mV (baseline). When measuring IKr, HMR-
1556 (500 nM) was used to completely block IKs, while dofetilide
(0.1 mM) was added to the bath solution when studying IKs. The
top panels of Figure 5A and 5B show original IKr and IKs current
traces in the absence and presence of 30 mM diclofenac, and
indicate a significant blockade of IKr (at 20 mV test potential; from
57.765.5 pA to 36.262.3 pA, n= 5 cells/4 animals, p,0.05) and
of IKs (at 20 mV test potential; from 229.6615.0 pA to
126.5610.5 pA, n = 6 cells/4 animals, p,0.05) by diclofenac.
The corresponding bottom panels show the current-voltage
relationships of IKr (Fig. 5A) and IKs (Fig. 5B) before and following
superfusion with 30 mM diclofenac.
ICa was recorded in the presence 3 mM 4-aminopyridine in
order to block Ito. The current was evoked by 400 ms-long
Figure 3. Effect of diclofenac on repolarization and TdP
incidence in anesthetized rabbits. (A) Frequency corrected QT
intervals (QTc) and (B) incidence of Torsades de Pointes ventricular
tachycardia (TdP) in anaesthetized rabbits before and following
dofetilide (25 mg/kg), dofetilide+diclofenac (3 mg/kg) and diclofenac,
diclofenac+dofetilide administration. *p,0.05 vs. control, +p,0.05 vs.
diclofenac, 1p,0.05 vs. dofetilide, n = 15 and 13 animals/group,
respectively. (C) Representative ECG recordings illustrate TdP de-
velopment only after dofetilide or diclofenac+dofetilide combination,
but not following diclofenac administration. #p,0.05 vs. baseline,
n = 13 and 15 animals/group, respectively.
doi:10.1371/journal.pone.0053255.g003
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depolarizing test pulses to voltages between 235 to +55 mV. The
holding potential was 280 mV and a 75 ms-long prepulse to
240 mV was applied in order to inactivate the sodium current.
The pulse frequency was 0.2 Hz. The amplitude of ICa was
defined as the difference between the peak inward current at the
beginning and the current at the end of the pulse. Diclofenac
(30 mM) slightly but statistically significantly decreased the
amplitude of the current (at 0 mV test potential; from
730.5679.8 pA to 623.2682.4 pA, n= 6 cells/4 animals,
p,0.05) as indicated on Figure 6.
Discussion
The main results of the present study show that in the normal
heart, diclofenac does not exert marked cardiac electrophysiolog-
ical effects and does not enhance proarrhythmic risk, however, in
hearts where repolarization reserve is attenuated, its moderate
inhibition of IKs and IKr may lead to prolongation of ventricular
repolarization and may also enhance proarrhythmic risk.
Our results indicate that diclofenac influences transmembrane
ionic currents in canine ventricular myocytes, inhibiting IKr, IKs
and ICa currents but leaving Ito and IK1 unchanged. Only a slight
action potential lengthening was induced in ventricular muscle
preparations and in Purkinje fibers the drug shortened the action
potential duration. The maximum upstroke velocity was decreased
in both preparations by diclofenac. However, larger repolarization
prolongation was observed when repolarization reserve was
impaired by previous application of BaCl2. In anaesthetized
rabbits, diclofenac did not prolong the QTc interval and did not
induce TdP when administered alone. In contrast, when
diclofenac was administered after the IKr blocker dofetilide it
further increased the QTc interval and the incidence of TdP. In
addition, dofetilide induced TdP in 20% of animals, however,
when dofetilide was administered after diclofenac, the incidence of
TdP was 62%.
For more than a decade, concerns about increased cardiovas-
cular risks associated with NSAID drugs have been increasing,
especially in patients with a history of cardiovascular disease
[21,22,23]. The latest network meta-analysis of the cardiovascular
safety of NSAID compounds involving more than 116 000 patients
clearly suggested that NSAID drug administration was associated
with elevated cardiovascular risk, and diclofenac was one of the
drugs associated with the highest risk of cardiovascular death [12].
It is not clear from this meta-analysis, however, how the risk of
serious ventricular arrhythmia induced sudden cardiac death was
influenced by NSAIDs.
The present study focused on the effects of diclofenac on cardiac
repolarization, action potential characteristics and on the main
transmembrane ionic currents in ventricular muscle, since little is
known about the direct cardiac electrophysiological effects and the
possible proarrhythmic potency of this drug. Most of the
information about the action of diclofenac on ionic currents arises
Figure 4. Lack of effect of diclofenac on the transient outward potassium (Ito) and on the inward rectifier potassium (IK1) currents in
canine ventricular myocytes. A, top: Representative Ito current traces under control conditions and after application of 50 mM diclofenac. A,
bottom: Current – voltage relationships of Ito under control conditions and in the presence of 50 mM diclofenac. Panel B shows steady-state current –
voltage relationships of IK1 before and after application of 50 mM diclofenac. Insets depict the voltage protocol applied during measurements. Data
are expressed as mean 6 SEM, n =number of measurements/number of animals.
doi:10.1371/journal.pone.0053255.g004
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from measurements in non-cardiac cells, activating the transient
outward K+ current [24] and inhibiting sodium current [25,26]. It
was also observed that diclofenac enhanced KCNQ2/Q3 currents
[27], others reported that the drug served as an activator of
KCNQ4 and a blocker of KCNQ5 channels [28]. The only ionic
current data obtained in ventricular cells were measured by
Yarishkin et al. [29], who described inhibition of L-type Ca2+
current by the drug in neonatal rat ventricular myocytes.
Our results showed that diclofenac did not influence Ito and IK1
currents even at high concentration but decreased the amplitude
of IKr and IKs currents in canine ventricular myocytes. In spite of
the significant IKr blockade by the drug just a small but statistically
significant action potential lengthening was detected following
diclofenac administration in canine ventricular muscle. Some of
our other observations may explain these seemingly conflicting
results. Diclofenac significantly decreased the maximum upstroke
velocity in canine ventricular muscle and also in Purkinje fibers
indicating the Na+ channel blocking property of the drug. It is well
established that the late or persistent component of the Na+
current contributes to the action potential plateau, which is most
significant in Purkinje fiber [16]. In Purkinje fiber, diclofenac
shortened the action potential duration most probably due to
inhibition of the late Na+ current. Therefore, blockade of this
current tends to limit the action potential prolongation resulting
from the IKr inhibition by diclofenac. Indeed, a similar reduction
of the action potential duration prolonging effect by additional ICa
inhibition was demonstrated earlier in the case of the neuroleptic
risperidone that blocks IKr [30]. Therefore, the slight decrease of
L-type Ca2+ current by high concentration of diclofenac found in
this study may also help to counteract the action potential
lengthening effect of IKr blockade. The key role of IKs in
ventricular repolarization was discussed in earlier works [7,8,31].
Full inhibition of IKs caused only a slight lengthening of
repolarization in ventricular preparations, thus in normal canine
ventricular muscle IKs plays a minor role in control of APD. This
current, however, could provide an important means of limiting
excessive APD lengthening when action potential duration is
prolonged beyond normal by other mechanisms, thus contributing
significantly to repolarization reserve [8]. Therefore, IKs blockade
caused by diclofenac might only marginally influence action
potential duration but attenuates repolarization reserve.
We characterized in vitro and in vivo electrophysiological effects
of diclofenac: (i) the drug at high concentration inhibits both
inward – depolarizing – and outward – repolarizing – trans-
membrane ionic currents in canine ventricular myocytes, (ii)
resulting in only slight repolarization lengthening of ventricular
muscle and shortening of the action potential in Purkinje fibers
with normal repolarization reserve; (iii) diclofenac did not prolong
the QTc interval in anaesthetized rabbits. This implies that
diclofenac may not augment spatial repolarization heterogeneity.
However, in preparations with impaired repolarization reserve,
much larger lengthening of the action potential duration was
observed after application of the drug. Moreover, in our in vivo
anaesthetized rabbit model when repolarization reserve was
Figure 5. Effect of diclofenac on the rapid (IKr) and slow (IKs) component of the delayed rectifier potassium currents in canine
ventricular myocytes. Top panels show representative current traces (A, IKr; B, IKs), bottom panels represent current – voltage relationships under
control conditions and in the presence of 30 mM diclofenac. Insets indicate the voltage protocol applied during measurements. Data are expressed as
mean 6 SEM, n =number of measurements/number of animals.
doi:10.1371/journal.pone.0053255.g005
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impaired, diclofenac further increased QTc interval and the
incidence of TdP while administered alone it did not induce any
TdP.
According to the concept of repolarization reserve [1,2,32],
normal repolarization is accomplished by multiple potassium
channels providing a strong safety reserve for repolarization. Since
inhibition or dysfunction of structural origin of one potassium
channel does not necessarily lead to clinically manifest pro-
longation of repolarization, other potassium channels can take
over the loss of function. However, a heart with impaired
repolarization reserve is more vulnerable to arrhythmia de-
velopment, since inhibition of another potassium channel by
drugs may lead to significant inhomogenous repolarization
prolongation and to serious cardiac dysrhythmias [3]. In the
present study, the influence of diclofenac on action potential
repolarization was also investigated after impairment of the
repolarization reserve by adding 30 mM BaCl2, which partially
blocks IK1 current. The drug induced a marked action potential
lengthening, i.e. the APD lengthening effect of diclofenac was
significantly larger in these conditions than in ventricular
preparations with normal repolarization reserve.
Repolarization reserve can be reduced by several congenital or
acquired pathophysiological conditions [3], as well as reversible
cardiac hyperthrophy (athlete’s heart). Downregulation or dys-
function of the IKs current plays a critical role in the development
of cardiac repolarization reserve impairment [33,8]. In compet-
itive athletes, slight impairment of repolarization reserve [34] does
not result in a significant risk of arrhythmia but together with
additional factors (increased sympathetic tone, seemingly harmless
medications, doping agents, dietary constituents, hypokalemia,
early and undiagnosed cardiomyopathy or other pathological
anomalies), these hits on repolarization may add up and can cause
repolarization abnormalities occasionally leading to sudden
cardiac death (for a recent review see [5]). In this regard, we
found higher beat-to-beat variability of the QT interval, a novel
ECG parameter characterizing temporal instability of cardiac
repolarization [35], in professional soccer players compared to
their age-matched controls with no significant sports activities
[36].
The applied concentration of diclofenac in the present study
was somewhat higher than the reported therapeutic blood level,
which is approximately 2–7 mM/L based on the data after 50 mg
oral administration of diclofenac [37,38]. Diclofenac strongly
binds to plasma albumin [39], complicating the comparison of
in vitro and in vivo data. In addition, substantial interpatient
variabilities in unbound NSAID plasma concentrations and a poor
correlation between concentration and therapeutic response to
NSAIDs have been found [39]. It is well known that top athletes
widely use NSAIDs, to treat their sports injuries frequently
diclofenac, in larger doses [13] that can result in significantly
higher plasma and tissue levels. In an in vivo animal study,
application of diclofenac in therapeutic doses resulted in higher
plasma concentration: a single 50 mg oral dose of diclofenac led to
6 mg/mL (approximately 20 mM/L) peak plasma concentration in
Beagle dogs [40]. In clinical settings, diclofenac plasma levels can
be increased by dietary constituents (e.g. grapefruit, pineapple
juices) and co-administered medications interfering with its
metabolism [41,42,43,44,45] or plasma protein binding [46].
Study Limitations
BaCl2 was used as a tool to impair repolarization reserve in
ventricular muscle preparations only, since in Purkinje fibers it was
reasonable to expect that BaCl2 would have affected the slope of
diastolic depolarization and would have influenced action
potential measurements.
The actual plasma levels of diclofenac in anesthetized rabbits
were not measured under the present experimental conditions, we
relied on firm data from the literature to determine the dose and
concentrations of diclofenac used in the experiments.
Conclusions
In the normal heart, diclofenac at therapeutic and even at higher
concentrations does not markedly influence ventricular repolari-
zation and arrhythmia risk. However, high-dose treatment with
the drug may enhance proarrhythmic risk in situations that lead to
reduced repolarization reserve. Therefore, individuals taking diclofenac
under proper medical control should not be concerned about
proarrhythmic side effects, however, its administration may add to
increased risk for serious arrhythmia development in persons
associated with subsidiary risk factors including certain diseases or
genetic defects that impair repolarization, as well as in individuals
taking part in top competitive sports activities. Additional clinical
studies are needed to elucidate whether diclofenac increases
proarrhythmic risk in patients with congenital and/or acquired
diseases and conditions associated with impaired repolarization
reserve.
Figure 6. Effect of diclofenac on the L-type calcium current in
canine ventricular myocytes. Top panel shows representative
current traces, bottom panel represents current – voltage relationships
under control conditions and in the presence of 30 mM diclofenac. Inset
indicates the voltage protocol applied during measurements. Data are
expressed as mean 6 SEM, n= number of measurements/number of
animals.
doi:10.1371/journal.pone.0053255.g006
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